MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cjca.2025.11.020

Медицинская библиотека · The Canadian journal of cardiology · 2025

Clinical Presentation and Midterm Results of Mitral Valve Surgery for Calcified Mitral Valve Disease---the MITRACURE Registry.

Suc Gaspard, Dreyfus Julien, Ternacle Julien, Le Tourneau Thierry, Demers Philippe, Guo Linrui, Nam Fu Angel Yi, Dib Jean Claude, Al Fadhalah Mohammad, Sokolov Thays, Anselmi Amedeo, Tchétché Didier, Meslin Ophélie Brault, Goutondji Ange, Lavie-Badie Yoan, Seknadji Patrick, Coisne Augustin, Arangalage Dimitri, Bernard Anne, Manian Usha, Kass Malek, Fiore Antonio, Maudiere Arnaud, Bohbot Yohann, Seemann Aurélien, Hammoudi Nadjib, Bière Loïc, Leroux Pierre-Yves, Forcillo Jessica, Jeu Antoine, Nejjari Mohammed, Huttin Olivier, Gilard Martine, Bouleti Claire, Harnett David T, Legare Jean-Francois, Moussi Thiziri Si, Ye Jian, Sportouch Catherine, Bittira Bindu, Munte Laura, Bauer Fabrice, Leong-Poi Howard, Hassanabad Ali Fatehi, Modine Thomas, Bernick Jordan, Wells George A, Gauda Roja, Iung Bernard, Kent William, Chu Michael W A, Bouchard Denis, Obadia Jean-François, Messika-Zeitoun David

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Calcified mitral valve disease (CMVD) is an increasingly recognized condition associated with specific management challenges. MITRACURE, a large, multicenter, observational registry conducted in France and Canada, provides real-world insights into the characteristics and outcomes of patients with CMVD undergoing MV surgery.

METHODS

Among the 3522 patients included in MITRACURE, patients identified with CMVD were matched 4:1 for age, sex, and concomitant procedures with patients with myxomatous MV disease.

RESULTS

Sixty patients (2%) with CMVD were matched to 240 with myxomatous MV disease. Compared with the myxomatous cohort, CMVD patients had a greater burden of cardiovascular risk factors, more comorbidities, and a more advanced presentation, with 70% vs 52% in New York Heart Association class III or IV (P = 0.01). In-hospital mortality and major complication rates (composite of death, cardiogenic shock/low cardiac output requiring inotropes, acute renal failure requiring dialysis, and stroke or transient ischemic attack) were significantly higher in CMVD than in myxomatous patients (20% vs 4% and 38% vs 20%, both P < 0.01). The median European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) measure was slightly higher in CMVD patients (3.5 [interquartile range 2.2-5.7]) compared to those with myxomatous disease (2.6 [interquartile range 1.5-4.2], P < 0.01). However, the observed mortality in the CMVD group was 3-4 times higher than predicted, whereas in the myxomatous group it was consistent with predicted values.

CONCLUSIONS

CMVD defines a high-risk surgical population with substantial baseline cardiovascular morbidity and markedly elevated postoperative mortality and complication rates that were substantially underestimated by EuroSCORE II emphasizing the need for refined risk prediction models and individualized management strategies in this subset of patients.

Для цитирования: Suc Gaspard, Dreyfus Julien, Ternacle Julien, Le Tourneau Thierry, Demers Philippe, Guo Linrui, Nam Fu Angel Yi, Dib Jean Claude, Al Fadhalah Mohammad, Sokolov Thays, Anselmi Amedeo, Tchétché Didier, Meslin Ophélie Brault, Goutondji Ange, Lavie-Badie Yoan, Seknadji Patrick, Coisne Augustin, Arangalage Dimitri, Bernard Anne, Manian Usha, Kass Malek, Fiore Antonio, Maudiere Arnaud, Bohbot Yohann, Seemann Aurélien, Hammoudi Nadjib, Bière Loïc, Leroux Pierre-Yves, Forcillo Jessica, Jeu Antoine, Nejjari Mohammed, Huttin Olivier, Gilard Martine, Bouleti Claire, Harnett David T, Legare Jean-Francois, Moussi Thiziri Si, Ye Jian, Sportouch Catherine, Bittira Bindu, Munte Laura, Bauer Fabrice, Leong-Poi Howard, Hassanabad Ali Fatehi, Modine Thomas, Bernick Jordan, Wells George A, Gauda Roja, Iung Bernard, Kent William, Chu Michael W A, Bouchard Denis, Obadia Jean-François, Messika-Zeitoun David. Clinical Presentation and Midterm Results of Mitral Valve Surgery for Calcified Mitral Valve Disease---the MITRACURE Registry.. The Canadian journal of cardiology. 2025. DOI: 10.1016/j.cjca.2025.11.020.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.